Ceramide induces pyroptosis through TXNIP/NLRP3/GSDMD pathway in HUVECs

BMC Mol Cell Biol. 2022 Dec 14;23(1):54. doi: 10.1186/s12860-022-00459-w.

Abstract

Background: Pyroptosis of endothelial cells is a new cause of endothelial dysfunction in multiple diseases. Ceramide acts as a potential bioactive mediator of inflammation and increases vascular endothelial permeability in many diseases, whether it can aggravate vascular endothelial injury by inducing cell pyroptosis remains unknown. This study was established to explore the effects of C8-ceramide (C8-Cer) on human umbilical vein vascular endothelial cells (HUVECs) and its possible underlying mechanism.

Methods: HUVECs were exposed to various concentrations of C8-Cer for 12 h, 24 h, 48 h. The cell survival rate was measured using the cell counting kit-8 assay. Western blotting and Real-time polymerase chain reaction (RT-PCR) were used to detect the pyroptosis-releated protein and mRNA expressions, respectively. Caspase-1 activity assay was used to detect caspase-1 activity. Hoechst 33342/propidium iodide double staining and flow cytometry were adopted to measure positive staining of cells. Lactate dehydrogenase release assay and enzyme-linked immunosorbent assay were adopted to measure leakage of cellular contents. FITC method was used to detect the permeability of endothelial cells. ROS fluorescence intensity were detected by flow cytometry.

Results: The viability of HUVECs decreased gradually with the increase in ceramide concentration and time. Ceramide upregulated the expression of thioredoxin interacting protein (TXNIP), NLRP3, GSDMD, GSDMD-NT, caspase-1 and Casp1 p20 at the protein and mRNA level in a dose-dependent manner. It also enhanced the PI uptake in HUVECs and upregulated caspase-1 activity. Moreover, it promoted the release of lactate dehydrogenase, interleukin-1β, and interleukin-18. Meanwhile, we found that ceramide led to increased vascular permeability. The inhibitor of NLRP3 inflammasome assembly, MCC950, was able to disrupt the aforementioned positive loop, thus alleviating vascular endothelial cell damage. Interestingly, inhibition of TXNIP either chemically using verapamil or genetically using small interfering RNA (siRNA) can effectively inhibit ceramide-induced pyroptosis and improved cell permeability. In addition, ceramide stimulated reactive oxygen species (ROS) generation. The pretreatment of antioxidant N-acetylcysteine (NAC), ROS scavenger, blocked the expression of pyroptosis markers induced by C8-cer in HUVECs.

Conclusion: The current study demonstrated that C8-Cer could aggravate vascular endothelial cell damage and increased cell permeability by inducing cell pyroptosis. The results documented that the ROS-dependent TXNIP/NLRP3/GSDMD signalling pathway plays an essential role in the ceramide-induced pyroptosis in HUVECs.

Keywords: Cell pyroptosis; Ceramide; Endothelial cell; TXNIP/NLRP3/GSDMD signalling pathway; Vascular endothelial cell.

MeSH terms

  • Carrier Proteins
  • Caspase 1 / genetics
  • Caspase 1 / metabolism
  • Caspase 1 / pharmacology
  • Ceramides / pharmacology
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Lactate Dehydrogenases / metabolism
  • NLR Family, Pyrin Domain-Containing 3 Protein* / genetics
  • NLR Family, Pyrin Domain-Containing 3 Protein* / metabolism
  • Phosphate-Binding Proteins / metabolism
  • Phosphate-Binding Proteins / pharmacology
  • Pore Forming Cytotoxic Proteins / metabolism
  • Pyroptosis* / genetics
  • RNA, Messenger / genetics
  • Reactive Oxygen Species / metabolism

Substances

  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Reactive Oxygen Species
  • Ceramides
  • Caspase 1
  • RNA, Messenger
  • Lactate Dehydrogenases
  • TXNIP protein, human
  • Carrier Proteins
  • GSDMD protein, human
  • Phosphate-Binding Proteins
  • Pore Forming Cytotoxic Proteins

Grants and funding